Clinical utility of comprehensive genomic profiling tests for advanced or metastatic solid tumor in clinical practice

被引：26

作者：

Ida, Hanae ^{[1
]}

Koyama, Takafumi ^{[1
]}

Mizuno, Takaaki ^{[1
]}

Sunami, Kuniko ^{[2
]}

Kubo, Takashi ^{[2
]}

Sudo, Kazuki ^{[1
,3
]}

Tao, Kayoko ^{[4
]}

Hirata, Makoto ^{[5
]}

Yonemori, Kan ^{[1
,3
]}

Kato, Ken ^{[6
,7
]}

Okusaka, Takuji ^{[8
]}

Ohe, Yuichiro ^{[9
]}

Matsui, Yoshiyuki ^{[10
]}

Yamazaki, Naoya ^{[11
]}

Ogawa, Chitose ^{[4
]}

Kawai, Akira ^{[12
]}

Narita, Yoshitaka ^{[13
]}

Esaki, Minoru ^{[14
]}

Yamamoto, Noboru ^{[1
,9
]}

机构：

[1] Natl Canc Ctr, Dept Expt Therapeut, Tokyo, Japan

[2] Natl Canc Ctr, Dept Lab Med, Tokyo, Japan

[3] Natl Canc Ctr, Dept Med Oncol, Tokyo, Japan

[4] Natl Canc Ctr, Dept Pediat Oncol, Tokyo, Japan

[5] Natl Canc Ctr, Dept Genet Med & Serv, Tokyo, Japan

[6] Natl Canc Ctr, Dept Gastrointestinal Med Oncol, Tokyo, Japan

[7] Natl Canc Ctr, Dept Head & Neck, Esophageal Med Oncol, Tokyo, Japan

[8] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan

[9] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan

[10] Natl Canc Ctr, Dept Urol, Tokyo, Japan

[11] Natl Canc Ctr, Dept Dermatol Oncol, Tokyo, Japan

[12] Natl Canc Ctr, Dept Musculoskeletal Oncol & Rehabil, Tokyo, Japan

[13] Natl Canc Ctr, Dept Neurosurg & Neurooncol, Tokyo, Japan

[14] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Surg, Tokyo, Japan

来源：

CANCER SCIENCE | 2022年 / 113卷 / 12期

关键词：

advanced solid tumor; common cancer; comprehensive genomic profiling; genomically matched therapy; investigational new drug;

D O I：

10.1111/cas.15586

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Previous clinical trials indicate that 10%-25% of patients received genomically matched therapy after comprehensive genomic profiling (CGP) tests. However, the clinical utility of CGP tests has not been assessed in clinical practice. We assessed the clinical utility of CGP tests for advanced or metastatic solid tumor and determined the proportion of patients receiving genomically matched therapy among those with common and non-common cancers. From August 2019 to July 2020, a total of 418 patients had undergone CGP tests, and the results were discussed through the molecular tumor board at our site. The median age of patients was 57 (range: 3-86) years. Colorectal cancer was the most common, with 47 (11%) patients. Actionable genomic alterations (median 3, range: 1-17) were identified in 368 (88.0%) of 418 patients. Druggable genomic alterations were determined in 196 (46.9%) of 418 patients through the molecular tumor board. Genomically matched therapy was administered as the subsequent line of therapy in 51 (12.2%) patients, which is comparable to the proportion we previously reported in a clinical trial (13.4%) (p = 0.6919). The proportion of patients receiving genomically matched therapy was significantly higher among those with common cancers (16.2%) than non-common cancers (9.4%) (p = 0.0365). Genomically matched therapy after the CGP tests was administered to 12.2% of patients, which is similar to the proportion reported in the previous clinical trials. The clinical utility of CGP tests in patients with common cancers greatly exceeded that in patients with non-common cancers.

引用

页码：4300 / 4310

页数：11

共 18 条

[1]

[Anonymous], LATEST DETAIL JRCTS0

[2]

[Anonymous], 2022, Home

[3]

[Anonymous], FOUNDATIONMEDICINE

[4]

[Anonymous], PRODUCTS GENETIC AK4

[5] Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors [J].

Cobain, Erin F. ;

Wu, Yi-Mi ;

Chugh, Rashmi ;

Worden, Francis ;

Smith, David C. ;

Schuetze, Scott M. ;

Zalupski, Mark M. ;

Sahai, Vaibhav ;

Alva, Ajjai ;

Schott, Anne F. ;

Caram, Megan E. V. ;

Hayes, Daniel F. ;

Stoffel, Elena M. ;

Jacobs, Michelle F. ;

Kumar-Sinha, Chandan ;

Cao, Xuhong ;

Wang, Rui ;

Lucas, David ;

Ning, Yu ;

Rabban, Erica ;

Bell, Janice ;

Camelo-Piragua, Sandra ;

Udager, Aaron M. ;

Cieslik, Marcin ;

Lonigro, Robert J. ;

Kunju, Lakshmi P. ;

Robinson, Dan R. ;

Talpaz, Moshe ;

Chinnaiyan, Arul M. .

JAMA ONCOLOGY, 2021, 7 (04) :525-533

[6]

Ebi Hiromichi, 2019, JCO Precis Oncol, V3, DOI 10.1200/PO.19.00291

[7] Identifying Opportunities and Challenges for Patients With Sarcoma as a Result of Comprehensive Genomic Profiling of Sarcoma Specimens [J].

Hay, Margaret A. ;

Severson, Eric A. ;

Miller, Vincent A. ;

Liebner, David A. ;

Vergilio, Jo-Anne ;

Millis, Sherri Z. ;

Chen, James L. .

JCO PRECISION ONCOLOGY, 2020, 4 :176-182

[8] OncoKids A Comprehensive Next-Generation Sequencing Panel for Pediatric Malignancies [J].

Hiemenz, Matthew C. ;

Ostrow, Dejerianne G. ;

Busse, Tracy M. ;

Buckley, Jonathan ;

Maglinte, Dennis T. ;

Bootwalla, Moiz ;

Done, James ;

Ji, Jianling ;

Raca, Gordan ;

Ryutov, Alex ;

Xu, Xinjie ;

Zhen, Chao Jie ;

Conroy, Jeffrey M. ;

Hazard, Florette K. ;

Deignan, Joshua L. ;

Rogers, Beverly B. ;

Treece, Amanda L. ;

Parham, David M. ;

Gai, Xiaowu ;

Judkins, Alexander R. ;

Triche, Timothy J. ;

Biegel, Jaclyn A. .

JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06) :765-776

[9] Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers [J].

Horak, Peter ;

Heining, Christoph ;

Kreutzfeldt, Simon ;

Hutter, Barbara ;

Mock, Andreas ;

Huellein, Jennifer ;

Froehlich, Martina ;

Uhrig, Sebastian ;

Jahn, Arne ;

Rump, Andreas ;

Gieldon, Laura ;

Moehrmann, Lino ;

Hanf, Dorothea ;

Teleanu, Veronica ;

Heilig, Christoph E. ;

Lipka, Daniel B. ;

Allgaeuer, Michael ;

Ruhnke, Leo ;

Lassmann, Andreas ;

Endris, Volker ;

Neumann, Olaf ;

Penzel, Roland ;

Beck, Katja ;

Richter, Daniela ;

Winter, Ulrike ;

Wolf, Stephan ;

Pfuetze, Katrin ;

Geoerg, Christina ;

Meissburger, Bettina ;

Buchhalter, Ivo ;

Augustin, Marinela ;

Aulitzky, Walter E. ;

Hohenberger, Peter ;

Kroiss, Matthias ;

Schirmacher, Peter ;

Schlenk, Richard F. ;

Keilholz, Ulrich ;

Klauschen, Frederick ;

Folprecht, Gunnar ;

Bauer, Sebastian ;

Siveke, Jens Thomas ;

Brandts, Christian H. ;

Kindler, Thomas ;

Boerries, Melanie ;

Illert, Anna L. ;

von Bubnoff, Nikolas ;

Jost, Philipp J. ;

Spiekermann, Karsten ;

Bitzer, Michael ;

Schulze-Osthoff, Klaus .

CANCER DISCOVERY, 2021, 11 (11) :2780-2795

[10] Clinical Utility of Next-Generation Sequencing-Based Panel Testing under the Universal Health-Care System in Japan: A Retrospective Analysis at a Single University Hospital [J].

Inagaki, Chiaki ;

Maeda, Daichi ;

Hatake, Kazue ;

Sato, Yuki ;

Hashimoto, Kae ;

Sakai, Daisuke ;

Yachida, Shinichi ;

Nonomura, Norio ;

Satoh, Taroh .

CANCERS, 2021, 13 (05) :1-14

← 1 2 →